Hence, anti-cancer drug targets may actively repress DVL and it may potentially block F-actin dynamics, which inhibits EMT process in cancer cells, and the overall phenomena, is indirectly regulated by OBSCN gene. This evidence concerns the gene OBSCN and cancer.